The immunology of B-1 cells: from development to aging

MS Mattos, S Vandendriessche, A Waisman… - Immunity & …, 2024 - Springer
B-1 cells have intricate biology, with distinct function, phenotype and developmental origin
from conventional B cells. They generate a B cell receptor with conserved germline …

The role of B-1 cells in cancer progression and anti-tumor immunity

N Rodríguez-Zhurbenko, AM Hernández - Frontiers in Immunology, 2024 - frontiersin.org
In recent years, in addition to the well-established role of T cells in controlling or promoting
tumor growth, a new wave of research has demonstrated the active involvement of B cells in …

[HTML][HTML] Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer

S Gomez, OL Cox, RR Walker III, U Rentia… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Novel therapies are urgently needed for ovarian cancer (OC), the fifth deadliest
cancer in women. Preclinical work has shown that DNA methyltransferase inhibitors …

Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint …

S Soussan, G Pupier, I Cremer, PE Joubert… - Frontiers in …, 2024 - frontiersin.org
The intricate relationship between anti-tumor immunity and autoimmunity is a complex yet
crucial aspect of cancer biology. Tumor microenvironment often exhibits autoimmune …

[HTML][HTML] Natural antibodies drive type 2 immunity in response to damage-associated molecular patterns

AB Mara, K Rawat, WT King, CV Jakubzick - JCI insight, 2024 - ncbi.nlm.nih.gov
Allergic airway disease (AAD) is an example of type 2 inflammation that leads to chronic
airway eosinophilia controlled by CD4 Th2 cells. Inflammation is reinforced by mast cells …

Reactivity graph yields interpretable IgM repertoire signatures as potential tumor biomarkers

D Ferdinandov, V Kostov, M Hadzhieva… - International Journal of …, 2023 - mdpi.com
Combining adaptive and innate immunity induction modes, the repertoire of immunoglobulin
M (IgM) can reflect changes in the internal environment including malignancies. Previously …

Loss of B1 and marginal zone B cells during ovarian cancer

J Maslanka, G Torres, J Londregan, N Goldman… - Cellular …, 2024 - Elsevier
Recent advances in immunotherapy have not addressed the challenge presented by
ovarian cancer. Although the peritoneum is an “accessible” locus for this disease there has …

Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model

H Su, H Geng, L Cai, M Xu, W **ng, W Long… - Cancer …, 2023 - Wiley Online Library
Objective In order to ensure the stable transcription of target genes, we constructed a
eukaryotic high expression vector carrying an immune‐check inhibitor PD‐1v and a variety …

Identification of stromal cell proportion-related genes in the breast cancer tumor microenvironment using CorDelSFS feature selection: implications for tumor …

S Guo, Y Ma, X Li, W Li, X He, Z Yuan, Y Hu - Frontiers in Genetics, 2023 - frontiersin.org
Background: The tumor microenvironment (TME) of breast cancer (BRCA) is a complex and
dynamic micro-ecosystem that influences BRCA occurrence, progression, and prognosis …

[PDF][PDF] Immunogenicity Threshold in Allogeneic Cells Impacts CTL Response to Nondominant Congenic Antigens

K Rawat, AB Mara, WT King, CF Nnam… - The Journal of …, 2023 - journals.aai.org
Transplantation and cancer expose the immune system to neoantigens, including
immunogenic (dominant and subdominant) and nonimmunogenic Ags with varying …